Drug Type Small molecule drug |
Synonyms (S)-(-)-alpha-Methyldopa, 3-Hydroxy-alpha-methyl-L-tyrosine, Alpha medopa + [23] |
Target |
Action agonists |
Mechanism ADRA2 agonists(Adrenergic receptors alpha-2 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (20 Dec 1962), |
RegulationFast Track (United States), Orphan Drug (United States) |
Molecular FormulaC20H32N2O11 |
InChIKeyYKFCISHFRZHKHY-NGQGLHOPSA-N |
CAS Registry41372-08-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00405 | Methyldopa |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | United States | 20 Dec 1962 | |
Hypertension | United States | 20 Dec 1962 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Retinopathy of Prematurity | Phase 2 | United States | - |
Not Applicable | 54 | ACE inhibitors | ralrdnvsqj(rdzbhltfks) = qeelswfhdg lgqhwldmuo (xkbdkpitia ) View more | Positive | 28 Aug 2020 | ||
ralrdnvsqj(rdzbhltfks) = qsnitjztdc lgqhwldmuo (xkbdkpitia ) View more | |||||||
Not Applicable | 30 | wropjrbvwp(qxiqcbqkyn) = satdxnjbng xymfycqsuj (yoplaxczpy, 104) View more | - | 29 Mar 2018 | |||
Not Applicable | Choroidal Neovascularization anti-VEGF antibody | 419 | jupsberpgd(fsxgzsmhzu) = mspvkqeyuz fengpyhmqu (ujnabfpuoj ) | - | 01 Mar 2012 | ||
jupsberpgd(fsxgzsmhzu) = mxrokivhyl fengpyhmqu (ujnabfpuoj ) |